AI assistant
GENEDRIVE PLC Share Issue/Capital Change 2022
7668_sha_2022-11-30_070c799d-f541-4653-8c04-e7b95321fd11.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 9723H
Genedrive PLC
30 November 2022
genedrive plc
("genedrive" or the "Company")
Block Listing Six Monthly Return
| Name of applicant | genedrive plc | |||
| Name of scheme | 2007 Share Option Scheme | |||
| Period of return: | From: | 28 May 2022 | To: | 30 November 2022 |
| Balance of unallocated securities under scheme(s) from previous return: | 139,226 shares | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | Nil | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | Nil | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 139,226 shares | |||
| Name of contact: | Russ Shaw CFO |
| Telephone number of contact: | +44 (0)161 989 0245 |
For enquires:
| genedrive plc | +44 (0)161 989 0245 | |
| David Budd: CEO / Russ Shaw: CFO | ||
| Peel Hunt LLP (Nominated Adviser and Joint Broker) | +44 (0)20 7418 8900 | |
| James Steel / Oliver Duckworth | ||
| finnCap (Joint Broker) | +44 (0)20 7220 500 | |
| Geoff Nash / George Dollemore / Nigel Birks / Alice Lane | ||
| Walbrook PR Ltd (Media Relations & Investor Relations) | +44 (0)20 7933 8780 or [email protected] | |
| Paul McManus / Anna Dunphy | +44 (0)7980 541 893 / +44 (0)7876 741 001 | |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BLREKLFLLFLBFBZ